These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5718817)

  • 21. [Treatment of hypertension. 3. Antihypertensive agents affecting catecholamine metabolism].
    Faulhaber HD; Gawellek F; Singer P
    Dtsch Gesundheitsw; 1968 Oct; 23(43):2017-24. PubMed ID: 5732807
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of alpha-methyl-dopa (Dopegyt) and other antihypertensive drugs (guanethidine, bethanidine) on the isotope renogram.
    Radó J; Bános C; Takó J; Szabó T; Borbély L; Szende L; Kapus I; Nagy M
    Ther Hung; 1969; 17(2):76-82. PubMed ID: 5807612
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of a new antihypertensive combination (cyclazenine + presinol)].
    Ambrosioni E
    G Clin Med; 1967 Nov; 48(11):1149-62. PubMed ID: 5617984
    [No Abstract]   [Full Text] [Related]  

  • 24. [Case reports on the use of the antihypertensive agent Tadip from a specialist's practice].
    Roder W
    Med Monatsschr; 1969 Feb; 23(2):80-4. PubMed ID: 5801509
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative assessment of the results of new antihypertensive drugs].
    Schubert R; Pasz T; Lindner O
    Munch Med Wochenschr; 1968 Jul; 110(27):1604-9. PubMed ID: 5756285
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 27. [A combination of 3 drugs for modern treatment of hypertension].
    Vorberg G
    Med Monatsschr; 1973 Sep; 27(9):418-20. PubMed ID: 4768201
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 29. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognosis in arteriel hypertension under treatment with antihypertensive drugs].
    Thygesen K; Harvald B
    Ugeskr Laeger; 1975 Jan; 137(5):241-5. PubMed ID: 1136030
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor.
    Mehta AB; Biswas AK; Pinto IJ; Sheth UK
    Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ciclazenine in the therapy of arterial hypertension].
    Busilacchi M; Perpignano G; Altieri P; Verzetti G
    Rass Int Clin Ter; 1969 May; 49(10):605-14. PubMed ID: 5784807
    [No Abstract]   [Full Text] [Related]  

  • 35. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of depression and dopegit on regional blood flow in patients with hypertension].
    Neiko EM; Berezhnitskiĭ MN; Shvedenko LA; Kupnovitskaia IG; Mikhal'chuk BD
    Vrach Delo; 1986 Mar; (3):16-9. PubMed ID: 2872749
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of arterial hypertension by guanoxan].
    França HH; Simão J; Baroni R
    Rev Paul Med; 1967 Apr; 70(4):172-8. PubMed ID: 5614421
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
    Baldrighi V; Baldrighi G; Ronzoni L; Aiazzi L; Caprioli G
    Arch Sci Med (Torino); 1977; 134(2):185-92. PubMed ID: 869702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cyclazenin in the treatment of hypertension].
    Gotzen R; Dissmann T
    Munch Med Wochenschr; 1967 Mar; 109(9):478-83. PubMed ID: 5631637
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of dopergit for treating hypertension in combination with diabetes mellitus].
    Lesnichiĭ AV
    Sov Med; 1972 Jun; 35(6):135-6. PubMed ID: 4668153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.